01 / 02FOCUS Protocol
MOTS-c M40 Performance Cycle Pen
MOTS-c mitochondrial cycle for cellular energy and metabolic performance.
Technical Specifications
Key Attributes
- AMPK activation — the cellular switch for metabolic efficiency and fat oxidation
- Improves insulin sensitivity and glucose uptake in muscle cells
- Supports mitochondrial biogenesis and cellular energy capacity
- Physical performance and endurance support through metabolic pathway optimization
- Available as a structured M40 cycle through private protocol access in Bangkok
Biohackr.Labs provides product education, protocol guidance, and private client support. Information on this website is not medical advice and does not replace consultation with a licensed healthcare professional.
What's Included
Premium hard case.
Everything included.
Every Biohackr.Labs pen ships in our premium white hard case — holographic logo, foam-fitted interior. Inside: the precision pen, ten individually sealed 31G 8mm micro needles, and all documentation needed to begin your protocol correctly.
Precision pen
Pre-filled, batch quality-controlled pen system ready at your confirmed starting dose.
10× 31G micro needles
31G 8mm individually sealed sterile micro needles. Ten included as standard with every pen.
Protocol card
Starting dose, titration schedule, session guidance, and what to expect — specific to your protocol.
Batch QC documentation
Batch reference, preparation date, and compound specification. Not boilerplate — specific to your order.
Storage & handling guide
Temperature requirements, travel guidance, and handling notes with Bangkok climate context.
WhatsApp support access
Direct channel access throughout your protocol for questions, dose adjustments, and guidance.
Cold-Chain Delivery
Professionally packed
for Bangkok logistics.
Every Biohackr.Labs order is individually sealed, temperature-controlled, and dispatched in protective cold-chain packaging engineered to maintain product integrity from preparation to your door.
2–8°C maintained
Insulated inner liner and cold-pack keep the product in range throughout Bangkok transit.
Discreet outer packaging
Plain kraft outer box — no branding, no product name, no external indication of contents.
Tamper-evident sealing
Every product is individually sealed before dispatch. Integrity is visible at handover.
Step 01
Protocol Overview
“MOTS-c mitochondrial cycle for cellular energy and metabolic performance.”
The MOTS-c M40 Performance Cycle Pen delivers 40 mg of MOTS-c across 200 precision clicks. MOTS-c is a mitochondrial-derived peptide — encoded within the mitochondrial genome rather than the nuclear genome — with an emerging research profile in cellular energy metabolism, insulin sensitivity, physical performance, and metabolic flexibility. The M40 pen delivers a structured performance cycle for clients focused on sustained energy output, metabolic efficiency, and cellular optimization.
Step 02
Mechanism of Action
MOTS-c acts as a mitochondrial signal peptide that regulates AMPK (AMP-activated protein kinase) — a master cellular energy sensor. When activated, AMPK shifts cells toward fat oxidation, improves insulin sensitivity, and enhances mitochondrial biogenesis. MOTS-c has been shown in research to improve glucose uptake in muscle cells, enhance metabolic flexibility, and support physical performance by optimising how cells generate and utilise energy at the mitochondrial level.
Suggested Use
Daily subcutaneous administration across a defined performance cycle. Cycle length and administration protocol confirmed through private onboarding.
Who This Protocol Is For
Designed for clients in Bangkok and Thailand focused on metabolic performance, energy optimization, body composition, or athletic output. Particularly relevant for those seeking performance support alongside or after Retatrutide protocols, or as a standalone mitochondrial optimization cycle.
Storage — Bangkok & Thailand
Refrigerate between 2–8°C. MOTS-c is sensitive to temperature variation. In Bangkok's climate, maintain consistent cold storage throughout the protocol cycle.
Private Access Required
All Biohackr.Labs protocols are guided through private client onboarding. Dosing and administration are confirmed per client before access is granted.
Enquire on WhatsAppThe Compound
What Is MOTS-c?
Mitochondrial-Derived Peptide — Metabolic Performance
MOTS-c is one of the most scientifically novel compounds in the Biohackr.Labs range. Unlike all other peptides — which are encoded by nuclear DNA — MOTS-c is encoded directly by the mitochondrial genome. It is a mitochondrial-derived peptide (MDP), acting as what researchers describe as a "mitochondrial hormone" or "mitokine" — a signal from the cell's energy-producing organelles to the rest of the body. MOTS-c levels rise naturally during exercise and decline with age, which led researchers to hypothesize that it may be a key mediator of exercise's metabolic benefits.
Mechanism of Action
How It Works
MOTS-c's primary mechanism is AMPK activation — triggering the "metabolic master switch" that shifts cells toward fat oxidation, improves glucose uptake, enhances insulin sensitivity, and promotes mitochondrial biogenesis (the creation of new mitochondria). Under metabolic stress — fasting, high-fat diet, or intense exercise — MOTS-c translocates from mitochondria to the cell nucleus, where it directly regulates gene expression. A 2021 study published in Nature Communications by Reynolds et al. demonstrated that MOTS-c functions as an exercise-induced regulator of age-dependent physical decline and muscle homeostasis in mice — the flagship peer-reviewed paper on the compound.
Evidence Level
Emerging research — published Nature study · Human trials beginning
Research Landscape
MOTS-c is in active research as of 2026. Key findings: reversed diet-induced obesity and age-dependent insulin resistance in mice (USC, 2018). Improved endurance performance in young mice; more dramatically improved performance in older mice — suggesting age-dependent benefit amplification (Reynolds et al., Nature 2021). A 2025 Frontiers study showed MOTS-c restored mitochondrial respiration in type 2 diabetic heart tissue. Kong et al. (2025) demonstrated potential senotherapeutic effects against pancreatic islet cell senescence. USADA has listed MOTS-c on its prohibited substance watch list — reflecting the assumption of performance benefit.
Biohacking & Community Context
MOTS-c sits at the frontier of the biohacking community's interest — it is too new and too scientifically novel for most users, but it's a staple in the most advanced longevity and performance circles. Commonly described as "exercise in a peptide" — the concept of triggering metabolic adaptations without the exercise itself, or dramatically amplifying exercise outcomes. The community primary use cases: body composition optimization, metabolic efficiency for athletes, mitochondrial health in the longevity context, and insulin sensitivity support for those managing metabolic health. Bryan Johnson (Blueprint) and similar extreme longevity practitioners have noted interest in mitochondrial-derived peptides as a category. Community reported effects: improved energy without stimulant effect, better body composition response to training, and enhanced fat oxidation.
Protocol Benefits
Reported Benefits & Research Findings
AMPK Activation — Metabolic Master Switch
Activates AMPK, triggering fat oxidation, glucose uptake enhancement, insulin sensitivity improvement, and mitochondrial biogenesis — the same cascade activated by exercise and fasting.
Exercise Mimetic Effects
MOTS-c levels rise naturally during exercise. Research shows it mediates many of exercise's metabolic benefits — making it potentially useful for amplifying training response or maintaining metabolic health when training volume is limited.
Insulin Sensitivity & Glucose Control
Enhances GLUT4 (glucose transporter) activity and cellular glucose uptake. Reversed diet-induced and age-dependent insulin resistance in multiple preclinical models. Emerging relevance for metabolic health optimization.
Age-Dependent Performance Enhancement
Notably, MOTS-c showed greater performance improvements in older mice than younger ones in Reynolds et al. (2021) — suggesting the benefit increases with age-related mitochondrial decline.
Mitochondrial Biogenesis
Promotes the creation of new mitochondria — increasing total cellular energy production capacity. This underlies sustained energy improvements reported in the biohacking community during MOTS-c protocols.
Research Data
Key Findings & Statistics
2021
Flagship Nature Communications publication
Reynolds et al. — "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis"
Nature Communications 2021
AMPK
Primary molecular target
AMP-activated protein kinase — the cellular metabolic master switch controlling fat burning, glucose uptake, and mitochondrial biogenesis
USC Research 2018
USADA
Prohibited substance watch list
US Anti-Doping Agency flagged MOTS-c as a substance of interest — reflecting the presumption of metabolic performance benefit
USADA 2024
2013
Year MOTS-c was discovered
Identified at USC in 2013 as the first mitochondrially-encoded signalling peptide — a fundamental discovery in molecular biology
Lee et al., 2013
MOTS-c is an early-stage research compound. All key findings to date are from preclinical (animal) models. Human trials are beginning but no human RCT data is yet published. This is a frontier compound — the science is genuinely exciting but human evidence will take years to accumulate. Use is based on the strength of mechanistic research and emerging preclinical data.
Same Collection
Related FOCUS Protocols
Private Access
Premium imported peptide pens in Bangkok.
Private protocol access · European-sourced · Quality-controlled · Thailand delivery
Enquire About MOTS-c M40 Performance Cycle Pen